Suchergebnisse - "Wilder-Smith, Annelies"

PubPharm (617)

1

Determining force of infection for chikungunya to support vaccine policy development

enthalten in: The Lancet. Infectious diseases | 2024

von Wilder-Smith, A. | Wilder-Smith, A.

ErratumIn: Lancet Infect Dis. 2024 Feb 29;:. - PMID 38432231

2

TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden

enthalten in: The Lancet. Global health | 2024

von Wilder-Smith, A.

3

Controlled human infection study underpins efficacy of the tetravalent live-attenuated dengue vaccine TV005

enthalten in: The Journal of clinical investigation | 2024

von Wilder-Smith, A.

4

The Dengue-in-Dhaka Initiative : results from a phase 2 trial evaluating the TV005 tetravalent dengue vaccine in Bangladesh

enthalten in: The Lancet. Infectious diseases | 2024

von Wilder-Smith, A.

5

Key considerations for the development of novel mRNA candidate vaccines in LMICs : A WHO/MPP mRNA Technology Transfer Programme meeting report

enthalten in: Vaccine | 2023

von Gsell, P. | Giersing, B. | Gottlieb, S. | +3

6

Conference report : WHO meeting summary on mRNA-based tuberculosis vaccine development

enthalten in: Vaccine | 2023

von Looney, M. | Hatherill, M. | Musvosvi, M. | +13

7

Seroprevalence of Zika in Brazil stratified by age and geographic distribution

enthalten in: Epidemiology and infection | 2023

von Botosso, V. | Precioso, A. | Wilder-Smith, A. | +9

8

Vaccine value profile for Chikungunya

enthalten in: Vaccine | 2023

von Flandes, X. | Hansen, C. | Palani, S. | +16

9

New Vaccines on the Immediate Horizon for Travelers: Chikungunya and Dengue Vaccines

enthalten in: Current infectious disease reports | 2023

von Menon, S. | Wilder-Smith, A.

10

Vaccines and therapeutics for immunocompromised patients with COVID-19

enthalten in: EClinicalMedicine | 2023

von Shoham, S. | Batista, C. | Ben Amor, Y. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[62]